Related Experiment Video
Updated: Mar 10, 2026

06:00
Determination of the Settling Rate of Clay/Cyanobacterial Floccules
Published on: June 11, 2018
7.5K
New Single-bottle Ceramic Primer: 6-month Case Report and Laboratory Performance
Fabiana Sf Siqueira1, Rodrigo S Alessi2, Andres Fm Cardenas3
1Department of Restorative Dentistry, School of Dentistry Ponta Grossa State University, Ponta Grosa, Paraná, Brazil.
The Journal of Contemporary Dental Practice
|December 15, 2016
Summary
A new self-etching glass-ceramic bonding agent (MEP) demonstrated effective 6-month clinical performance and comparable in vitro bond strength to traditional methods for lithium disilicate restorations. This simplifies dental esthetic procedures.
Area of Science:
- Dental Materials Science
- Adhesive Dentistry
- Biomaterials
Background:
- A novel self-etching glass-ceramic bonding agent, Monobond Etch and Prime (MEP), combines acid conditioning and silanes in a single bottle.
- This simplifies the bonding procedure for lithium disilicate (LD) restorations, reducing steps and chair time.
- A case report evaluated its 6-month clinical performance and in vitro bond strength compared to traditional hydrofluoric acid (HF) etching.
Observation:
- A 42-year-old female patient received esthetic treatment including LD crowns and veneers.
- After 6 months, no marginal defects such as staining, gaps, or fractures were observed.
- In vitro testing showed microshear bond strength to LD was statistically similar between MEP and HF conditioning.
Findings:
- The self-etching glass-ceramic bonding agent (MEP) exhibited favorable in vitro bond strength to lithium disilicate.
- Clinical follow-up at 6 months revealed no adverse effects or marginal deterioration.
- MEP demonstrated comparable bond strength to conventional hydrofluoric acid etching.
Implications:
- The new self-etching bonding agent offers a simplified, efficient alternative for esthetic dental bonding procedures.
- It shows promise for reliable bonding of lithium disilicate restorations.
- Further long-term clinical studies are recommended to validate its performance.

